Skip Navigation



Rheumatology Advance Access published online on April 3, 2008

Rheumatology, doi:10.1093/rheumatology/ken118
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/7/946    most recent
ken118v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yao, Q.
Right arrow Articles by Furst, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, Q.
Right arrow Articles by Furst, D. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Review

Autoinflammatory diseases: an update of clinical and genetic aspects

Q. Yao and D. E. Furst

Division of Rheumatology, David Geffen Medical School at UCLA, Los Angeles, CA, USA.

Correspondence to: D. E. Furst, Division of Rheumatology, UCLA, 1000 Veteran Ave., Rehab 39-52, Los Angeles, CA 90095, USA. E-mail: defurst{at}mednet.ucla.edu


   Abstract

To review clinical manifestations and genetic features of the autoinflammatory diseases, a group of rare, genetically defined diseases which have been newly grouped into a coherent whole. We performed a literature review using the keywords ‘periodic fever syndrome’, ‘autoinflammatory disease’ and ‘therapy’. All relevant original and review articles in English were reviewed. A case report of each autoinflammatory disease was excerpted from the literature and presented. This review summarizes the clinical manifestations, genetic analysis and therapy of FMF, TNF-{alpha} receptor-associated periodic fever syndrome, hyperimmunoglobulinaemia D periodic fever syndrome and cryopyrin-associated periodic fever syndrome. These diseases have periodic fever, are hereditary and recurrent, with elevated acute-phase reactants. Differentiating features of these disorders are tabulated. Autoinflammatory diseases have some communalities in their presentation although they represent a relatively diverse group of genetically associated diseases.

KEY WORDS: Autoinflammatory disease, Familial Mediterranean fever, Tumour necrosis factor a receptor associated periodic fever syndrome, Hyperimmunoglobulinemia D periodic fever syndrome, Cryopyrin, Genetic analysis, Amyloidosis, Therapy, TNF{alpha} blocker, Interleukin-1 receptor antagonist

Submitted 24 January 2008; Accepted 18 February 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
L. Garzoni, F. Vanoni, M. Rizzi, G. D. Simonetti, B. G. Simonetti, G. P. Ramelli, and M. G. Bianchetti
Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature
Rheumatology, December 1, 2009; 48(12): 1524 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Lainka, U. Neudorf, P. Lohse, C. Timmann, S. Stojanov, K. Huss, R. von Kries, and T. Niehues
Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics
Rheumatology, August 1, 2009; 48(8): 987 - 991.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.